港股異動丨光伏太陽能股飆升,美商務部考慮撤消部分中國光伏電池税項
美國商務部10月21日起啟動變更情況審查(CCR),考慮部分撤銷中國晶體硅光伏電池的反傾銷税和反補貼税(AD/CVD),並邀請相關各方發表意見,所涉產品為某些小型、低瓦數、離網晶硅光伏(CSPV)電池。港股市場光伏股集體飆升,其中,卡姆丹克太陽能和順風清潔能源升超30%,協鑫科技升超20%,陽光能源升超18%,福萊特玻璃升13%,信義光能升超12%,彩虹新能源升超11%,新特能源升超10%,協鑫新能源升6%,信義能源升近5%。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.